Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orthocell Ltd (AU:OCC)
ASX:OCC
Holding AU:OCC?
Track your performance easily
OCC Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.35 - AU$0.77
Previous CloseAU$0.64
Volume155.47K
Average Volume (3M)572.21K
Market Cap
AU$155.31M
Enterprise ValueAU$142.52M
Total Cash (Recent Filing)AU$11.02M
Total Debt (Recent Filing)AU$507.56K
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. Volume817,800
30 Day Avg. Volume572,210
Standard Deviation0.13
R-Squared0.18
Alpha0.00191
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)48.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.32Price Target Upside94.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Orthocell Ltd News
PremiumCompany Announcements
Orthocell Ltd Announces AGM Supplementary NoticePremiumCompany Announcements
Orthocell Expands ASX Listing with New Securities
PremiumCompany Announcements
Orthocell Ltd Secures $17 Million for US Expansion
PremiumCompany Announcements
Orthocell Ltd Announces Expiration of 125,000 OptionsPremiumCompany Announcements
Orthocell Ltd Lists New Shares on ASX
PremiumCompany Announcements
Orthocell Ltd Announces AGM and Global Expansion
PremiumCompany Announcements
Orthocell Ltd Announces New ASX Securities PlacementPremiumCompany Announcements
Orthocell Secures $17M for US Launch and ExpansionOptions Prices
Currently, No data available
---
Ownership Overview
OCC FAQ
What was Orthocell Ltd’s price range in the past 12 months?
Orthocell Ltd lowest share price was AU$0.35 and its highest was AU$0.77 in the past 12 months.
What is Orthocell Ltd’s market cap?
Currently, no data Available
When is Orthocell Ltd’s upcoming earnings report date?
Orthocell Ltd’s upcoming earnings report date is Mar 04, 2025 which is in 112 days.
How were Orthocell Ltd’s earnings last quarter?
Orthocell Ltd released its earnings results on Aug 30, 2024. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.
Is Orthocell Ltd overvalued?
According to Wall Street analysts Orthocell Ltd’s price is currently Undervalued.
Does Orthocell Ltd pay dividends?
Orthocell Ltd does not currently pay dividends.
What is Orthocell Ltd’s EPS estimate?
Orthocell Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orthocell Ltd have?
Orthocell Ltd has 239,114,430 shares outstanding.
What happened to Orthocell Ltd’s price movement after its last earnings report?
Orthocell Ltd reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.556%.
Which hedge fund is a major shareholder of Orthocell Ltd?
Currently, no hedge funds are holding shares in AU:OCC
---
Orthocell Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$1.32 (94.12% Upside)
AU$1.32 (94.12% Upside)
Blogger Sentiment
Bullish
AU:OCC Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
62.02%
12-Months-Change
Fundamentals
Return on Equity
-134.46%
Trailing 12-Months
Asset Growth
-10.10%
Trailing 12-Months
Company Description
Orthocell Ltd
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.
---
OCC Stock 12 Month Forecast
Average Price Target
AU$1.32
▲(94.12% Upside)
Technical Analysis
Aroa Biosurgery Ltd
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
PainChek Ltd
―
Invex Therapeutics Ltd.
―
Best Analysts Covering OCC
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+60.13%
reiterated a buy rating 20 days ago
Copying Tanushree Jain's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +60.13% per trade.
---